These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23789947)

  • 1. Targeting transporters for CNS drug delivery.
    Ronaldson PT
    Curr Pharm Des; 2014; 20(10):1419-21. PubMed ID: 23789947
    [No Abstract]   [Full Text] [Related]  

  • 2. Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?
    Sanchez-Covarrubias L; Slosky LM; Thompson BJ; Davis TP; Ronaldson PT
    Curr Pharm Des; 2014; 20(10):1422-49. PubMed ID: 23789948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of therapeutics to the central nervous system.
    Chambers JJ
    Adv Drug Deliv Rev; 2012 May; 64(7):589. PubMed ID: 22388004
    [No Abstract]   [Full Text] [Related]  

  • 4. Human ABC transporters at blood-CNS interfaces as determinants of CNS drug penetration.
    Chaves C; Shawahna R; Jacob A; Scherrmann JM; Declèves X
    Curr Pharm Des; 2014; 20(10):1450-62. PubMed ID: 23789951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zebrafish as a model to study drug transporters at the blood-brain barrier.
    Umans RA; Taylor MR
    Clin Pharmacol Ther; 2012 Nov; 92(5):567-70. PubMed ID: 23047649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for drug delivery to the central nervous system by systemic route.
    Kasinathan N; Jagani HV; Alex AT; Volety SM; Rao JV
    Drug Deliv; 2015 May; 22(3):243-57. PubMed ID: 24471801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted drug delivery to central nervous system (CNS) for the treatment of neurodegenerative disorders: trends and advances.
    Goyal K; Koul V; Singh Y; Anand A
    Cent Nerv Syst Agents Med Chem; 2014; 14(1):43-59. PubMed ID: 25360772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting CNS transporters for treatment of neurodegenerative diseases.
    Jedlitschky G; Grube M; Mosyagin I; Kroemer HK; Vogelgesang S
    Curr Pharm Des; 2014; 20(10):1523-33. PubMed ID: 23789959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prodrug approaches to reduce hyperexcitation in the CNS.
    Vytla D; Combs-Bachmann RE; Hussey AM; McCarron ST; McCarthy DS; Chambers JJ
    Adv Drug Deliv Rev; 2012 May; 64(7):666-85. PubMed ID: 22138074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approaches to CNS Drug Delivery with a Focus on Transporter-Mediated Transcytosis.
    Abdul Razzak R; Florence GJ; Gunn-Moore FJ
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31242683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomaterial-mediated CNS delivery of diagnostic and therapeutic agents.
    Biddlestone-Thorpe L; Marchi N; Guo K; Ghosh C; Janigro D; Valerie K; Yang H
    Adv Drug Deliv Rev; 2012 May; 64(7):605-13. PubMed ID: 22178615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel and emerging strategies in drug delivery for overcoming the blood-brain barrier.
    Stenehjem DD; Hartz AM; Bauer B; Anderson GW
    Future Med Chem; 2009 Dec; 1(9):1623-41. PubMed ID: 21425983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinatorial approaches for the identification of brain drug delivery targets.
    Stutz CC; Zhang X; Shusta EV
    Curr Pharm Des; 2014; 20(10):1564-76. PubMed ID: 23789958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The concept of fraction of drug transported (ft ) with special emphasis on BBB efflux of CNS and antiretroviral drugs.
    Prasad B; Unadkat JD
    Clin Pharmacol Ther; 2015 Apr; 97(4):320-3. PubMed ID: 25669655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mathematical Modeling and Simulation to Investigate the CNS Transport Characteristics of Nanoemulsion-Based Drug Delivery Following Intranasal Administration.
    Kadakia E; Bottino D; Amiji M
    Pharm Res; 2019 Mar; 36(5):75. PubMed ID: 30923914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug transport across the blood-brain barrier. III. Mechanisms and methods to improve drug delivery to the central nervous system.
    Van Bree JB; De Boer AG; Danhof M; Breimer DD
    Pharm World Sci; 1993 Feb; 15(1):2-9. PubMed ID: 8485503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of membrane transporters in drug delivery to brain tumors.
    Nies AT
    Cancer Lett; 2007 Aug; 254(1):11-29. PubMed ID: 17275180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal drug delivery to the central nervous system: present status and future outlook.
    Tayebati SK; Nwankwo IE; Amenta F
    Curr Pharm Des; 2013; 19(3):510-26. PubMed ID: 23116337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of blood-brain barrier transporters in pathophysiology and pharmacotherapy of stroke.
    Shah K; Abbruscato T
    Curr Pharm Des; 2014; 20(10):1510-22. PubMed ID: 23789950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Pathways for CNS Drug Delivery Across the Blood-Cerebrospinal Fluid Barrier.
    Strazielle N; Ghersi-Egea JF
    Curr Pharm Des; 2016; 22(35):5463-5476. PubMed ID: 27464721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.